An immunotherapy combination that could ‘change the landscape’ of cancer treatment

A pair of new studies suggest that combining two different kinds of inhibitors could be a new effective approach to immunotherapy.

June 21, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | New immunotherapy combination could 'change the landscape' of cancer treatment Two types of drugs, checkpoint inhibitors and JAK inhibitors, provide an unexpected synergy in treatment, according to new studies published in Science. By Angus Chen STAT+ | Ginkgo Bioworks lays off 158 employees, with more to come The once fast-growing life sciences firm is slashing expenses amid financial woes. By Jonathan Saltzman — Boston Globe How a Baltimore neuroscience study is rewriting Black America's relationship with medical research Well over 100 Black Baltimoreans donated the brains of their deceased loved ones for a study of genetics and neurological conditions. By Alia Sajani

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser